Asian markets ended mixed on Monday, despite news that US lawmakers finally set a deal for a nearly $900 billion Covid-19 financial package for American families and businesses. Faltering trade negotiations between Britain and the European Union put more pressure on market. The United Kingdom has gone back into strict lockdown due to the discovery of the new strain of the Sars-CoV-2 virus, which causes Covid-19, weeks after it started vaccinating against the virus. Chinese shares ended higher as the country's central bank kept its key benchmark lending rate unchanged, but rising Sino-US tensions could continue to weigh on the market.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3,420.57 | 25.67 | 0.76 |
Hang Seng | 26,306.68 | -191.92 | -0.72 |
Jakarta Composite | 6,165.62 | 61.30 | 1.00 |
KLSE Composite | 1,647.89 | -4.60 | -0.28 |
Nikkei 225 | 26,714.42 | -48.97 | -0.18 |
Straits Times | 2,846.52 | -2.46 | -0.09 |
KOSPI Composite | 2,778.65 | 6.47 | 0.23 |
Taiwan Weighted | 14,384.96 | 135.00 | 0.95 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: